Wise Medical (688580.SH) Announces 2021 Restricted Stock Incentive Plan with Initial Grant Price of RMB 40 per Share

VISHEE (688580.SH) Announced the 2021 Restricted Stock Incentive Plan. The number of restricted stocks proposed to be granted to incentive recipients under this plan is 1.0731 million shares, accounting for 1.57% of the company's total share capital of 68.346667 million shares as of the announcement date of the draft of this incentive plan.

Among them, 858,500 restricted shares were granted initially, accounting for 1.26% of the company’s total share capital on the announcement date of the draft equity incentive plan and 80.00% of the total number of restricted shares proposed to be granted under the plan; 214,600 shares were reserved, accounting for 0.31% of the company’s total share capital on the announcement date of the draft equity incentive plan, with the reserved portion representing 20.00% of the total number of restricted shares proposed to be granted under the plan.

The initial grant of this incentive plan covers a total of 100 recipients, including directors, senior management, core technical personnel, and other personnel deemed by the Board of Directors to require incentives, who were employed by the Company (including its subsidiaries, hereinafter referred to as the same) at the time of the Company’s announcement of this incentive plan.

Furthermore, the grant price for the restricted shares awarded to the incentive recipients in the initial grant is RMB 40.00 per share. The validity period shall commence on the grant date of the restricted shares and end on the date when all restricted shares granted to the incentive recipients are either vested or forfeited and become invalid, with a maximum duration not exceeding 48 months.